These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17220044)

  • 21. [Splenectomy and pneumococcal vaccination].
    Jeurissen A
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1142-3; author reply 1143. PubMed ID: 12822528
    [No Abstract]   [Full Text] [Related]  

  • 22. Pneumococcal vaccines in India.
    Dutta AK; Aggarwal A
    Indian J Pediatr; 2001 Mar; 68 Suppl 1():S39-43. PubMed ID: 11411384
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine.
    Palmu A; Jokinen J; Kilpi T;
    Vaccine; 2008 May; 26(20):2466-70. PubMed ID: 18420315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
    Pletz MW; Maus U; Hohlfeld JM; Lode H; Welte T
    Dtsch Med Wochenschr; 2008 Feb; 133(8):358-62. PubMed ID: 18270917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction.
    Dagan R; Frasch C
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S63-5. PubMed ID: 19325448
    [No Abstract]   [Full Text] [Related]  

  • 26. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].
    Hartwig NG; Rümke HC
    Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2592; author reply 2593. PubMed ID: 18074732
    [No Abstract]   [Full Text] [Related]  

  • 27. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
    Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of pneumococcal disease among adults.
    Maxim RB
    Med Health R I; 2001 May; 84(5):174-5. PubMed ID: 11392959
    [No Abstract]   [Full Text] [Related]  

  • 29. Pneumococcal vaccine concerns: shape-shifters and beyond.
    Singh NK
    Vaccine; 2007 Jul; 25(29):5244-5. PubMed ID: 17566614
    [No Abstract]   [Full Text] [Related]  

  • 30. Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.
    Paradiso P
    Vaccine; 2009 Aug; 27 Suppl 3():C15-8. PubMed ID: 19683657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal seroepidemiology in Turkey: implications for vaccine coverage.
    Erdem H; Sener B
    Vaccine; 2008 Mar; 26(10):1271-3. PubMed ID: 18272259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 35. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Under usage of conjugate pneumococcal vaccine in the Irish neonatal population.
    Breatnach C; McMahon P
    Ir Med J; 2007 Jan; 100(1):345. PubMed ID: 17380930
    [No Abstract]   [Full Text] [Related]  

  • 38. Seven-valent pneumococcal conjugate vaccines for developing countries.
    Obaro S
    Expert Rev Vaccines; 2009 Aug; 8(8):1051-61. PubMed ID: 19627187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.
    Prymula R; Chlibek R; Splino M; Kaliskova E; Kohl I; Lommel P; Schuerman L
    Vaccine; 2008 Aug; 26(35):4563-70. PubMed ID: 18602724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
    Dagan R
    Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.